Related Experiment Video
Updated: Jul 22, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus
Mario Gaudino1, Antonino Di Franco1, Davide Cao2
1Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York, USA.
Insights
Women experience worse outcomes for coronary artery disease (CAD) due to biological and sociocultural factors. This review highlights sex-specific differences in CAD treatment outcomes, emphasizing the need for tailored strategies.
Area of Science:
- Cardiology
- Sex-based differences in medicine
- Clinical outcomes research
Background:
- Coronary artery disease (CAD) affects men and women differently, with women often experiencing poorer outcomes.
- Biological and sociocultural factors contribute to these sex-based disparities in CAD epidemiology and treatment.
- Existing clinical studies inadequately represent women, hindering the development of sex-specific management guidelines.
Purpose of the Study:
- To review current evidence on sex-related differences in coronary artery disease (CAD).
- To focus on differential outcomes following medical therapy, percutaneous coronary interventions, and coronary artery bypass surgery in men versus women.
Main Methods:
- Systematic review of existing literature on sex differences in CAD.
- Analysis of outcomes data from medical therapy, percutaneous coronary interventions, and coronary artery bypass surgery.
Main Results:
- Women exhibit higher residual platelet reactivity on antiplatelet drugs compared to men.
- Women face increased adverse cardiovascular outcomes after percutaneous coronary revascularization.
- Women report higher operative and long-term mortality rates following coronary artery bypass surgery.
Conclusions:
- Significant sex-based differences exist in CAD outcomes across various treatment modalities.
- Underrepresentation of women in clinical trials limits understanding and addressing these disparities.
- Development and implementation of sex-specific management strategies for CAD are crucial.
Abstract:
Biological and sociocultural differences between men and women are complex and likely account for most of the variations in the epidemiology and treatment outcomes of coronary artery disease (CAD) between the 2 sexes. Worse outcomes in women have been described following both conservative and invasive treatments of CAD. For example, increased levels of residual platelet reactivity during treatment with antiplatelet drugs, higher rates of adverse cardiovascular outcomes following percutaneous coronary revascularization, and higher operative and long-term mortality after coronary bypass surgery have been reported in women compared with in men. Despite the growing recognition of sex-specific determinants of outcomes, representation of women in clinical studies remains low and sex-specific management strategies are generally not provided in guidelines. This review summarizes the current evidence on sex-related differences in patients with CAD, focusing on the differential outcomes following medical therapy, percutaneous coronary interventions, and coronary artery bypass surgery.
More Related Videos
Related Concept Videos
Pericarditis III: Medical Management
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care

